Business · 02/08/2004Updated: 10/17/2026 · 1 min read
FDA Proposes Changes to Over-the-Counter Nasal Decongestant Drug Products
Summary
The Food and Drug Administration (FDA) is proposing to update the labeling of over-the-counter nasal decongestant drug products to remove a specific indication and prohibit the use of certain terms, as part of its ongoing review of these products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →